申请人:Rhone-Poulenc Sante
公开号:US04980356A1
公开(公告)日:1990-12-25
Compounds of formula: ##STR1## and their salts, in which R.sub.1 represents polyfluoroalkoxy, and R.sub.2 represents alkyl, alkenyl (3-6 C), [cycloalkyl (3-6 C)]-alkyl, carbamoylalkyl, dialkylcarbamoylalkyl, acylaminoalkyl, phenylthioalkyl, hydroxyalkyl, cyanoalkyl, sulphamoylethyl, N-alkylsulphamoylethyl, pyridylthioalkyl, pyridiylalkylthioalkyl, pyridylsulphinylalkyl, alkynyl (3-6 C), phenylsulphinylalkyl, halophenylthioalkyl, (2,2,2-trifluoroethylthio)alkyl, 2-dialkylaminopropyl, pyrimidinylsulphinylalkyl, pyridylalkylsulphinylalkyl, halophenylsulphinylalkyl or (2,2,2-trifluoroethylsulphinyl)alkyl are useful in the treatment of medical conditions associated with the effects of glutamate.
式为:##STR1##及其盐,其中R.sub.1代表多氟烷氧基,R.sub.2代表烷基,烯基(3-6 C),[环烷基(3-6 C)]-烷基,氨基甲酰烷基,二烷基氨基甲酰烷基,酰胺基烷基,苯硫基烷基,羟基烷基,氰基烷基,磺酰乙基,N-烷基磺酰乙基,吡啶硫基烷基,吡啶烷基硫基烷基,吡啶磺氧基烷基,炔基(3-6 C),苯基磺氧基烷基,卤代苯基硫基烷基,(2,2,2-三氟乙硫基)烷基,2-二烷基氨基丙基,嘧啶磺氧基烷基,吡啶烷基磺氧基烷基,卤代苯基磺氧基烷基或(2,2,2-三氟乙磺氧基)烷基在治疗与谷氨酸作用有关的医疗状况中是有用的。